/C O R R E C T I O N -- Luminex Corporation/
03 March 2006 - 8:21AM
PR Newswire (US)
In the news release, Luminex Corporation (Nasdaq: LMNX) to Present
at 2006 Lehman Brothers Conference, issued yesterday, March 1, by
Luminex Corporation over PR Newswire, we are advised by a
representative of the company that the first paragraph should read
"Ninth Annual Lehman Brothers Global Healthcare Conference to be
held March 8-10, 2006" rather than "March 7-9, 2006" and the second
paragraph, first sentence should read "Harriss T. Currie, chief
financial officer, will begin at 9:30 a.m. Eastern time on Friday,
March 10, 2006" rather than "Thursday, March 9, 2006" as originally
issued inadvertently. Complete, corrected release follows: AUSTIN,
Texas, March 1 /PRNewswire-FirstCall/ -- Luminex Corporation
(NASDAQ:LMNX) today announced that management will present at the
Ninth Annual Lehman Brothers Global Healthcare Conference to be
held March 8-10, 2006, at the Loews Miami Beach Hotel, South Beach,
Florida. The investor presentation by Patrick J. Balthrop, chief
executive officer, and Harriss T. Currie, chief financial officer,
will begin at 9:30 a.m. Eastern time on Friday, March 10, 2006. The
presentation will be webcast live and may be accessed at Luminex
Corporation's website at http://www.luminexcorp.com/. Simply log on
to the web at the address above, go to the Company section and
access the Investor Relations link. Please go to the website at
least 15 minutes prior to the event to register, download and
install any necessary audio/video software. If you are unable to
participate during the live webcast, the presentation will be
archived for one year on the website using the 'replay' link. The
use of pop-up blocking software may impair your ability to view
webcasts. If you use this software, press and hold the CTRL key
when you click on the Register button. Please contact your IT group
if you are unable to override this feature. Unauthorized recording
or downloading of this event is not permitted. Luminex Corporation
develops, manufactures and markets proprietary biological testing
technologies with applications throughout the life sciences
industry. The Company's xMAP(R) system is an open-architecture,
multi-analyte technology platform that delivers fast, accurate and
cost-effective bioassay results to markets as diverse as
pharmaceutical drug discovery, clinical diagnostics and biomedical
research, including the genomics and proteomics research markets.
The Company's xMAP technology is sold worldwide and is in use in
leading research laboratories as well as major pharmaceutical,
diagnostic and biotechnology companies. Further information on
Luminex Corporation or xMAP can be obtained on the Internet at
http://www.luminexcorp.com/. Contact: Harriss T. Currie Vice
President, Finance and Chief Financial Officer 512-219-8020
DATASOURCE: Luminex Corporation CONTACT: Harriss T. Currie, Vice
President, Finance and Chief Financial Officer of Luminex
Corporation, +1-512-219-8020, or Web site:
http://www.luminexcorp.com/
Copyright
Luminex (NASDAQ:LMNX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Luminex (NASDAQ:LMNX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Luminex Corporation (NASDAQ): 0 recent articles
More Luminex (MM) News Articles